A New Class of Phase 0 Human Trials™
Organs donated for research and revived with perfusion technology enable a new class of Phase 0 Human Organ Trials™ that can integrate every source of human data to answer questions that are impossible with current Phase I/II clinical trials or preclinical models.
Human Organs are the Rosetta Stone
A functioning human organ outside the body creates an unparalleled source of human data.
This new data source allows us to contextualize and interpret the other layers of the human data stack.
Most importantly, this approach allows us to honor the profound gift that is every donated organ by creating a legacy for every donor and their families.
By uniting academic institutions, hospitals, and pharma in one ecosystem we can enable the entire biomedical community to focus on enabling better drugs, faster.
No risk to patients By testing directly on donated human organs
‘Impossible’ research That could never be done in living patients
Accelerated innovation From 10+ years to <1 month for first human results